Online Seminar 2019 - How to prepare for and host a FDA inspection and respond to 483’s
Topics/Call fo Papers
Overview
In this webinar you will learn how to prepare for an inspection and how to respond to a 483 or Warning letter if you receive one. You will learn about the types of FDA inspections, preparations such as assigning personnel to specific tasks for the inspection, facility requirements to support the inspection ( front room, back room), the value of mock audits, how personnel should conduct themselves during the inspection, the inspection process and how to respond to 483s and warning letters. How to respond and when is critically important. Also covered will be the FDA’s rights during the inspection and documentation you are not required to show them.
Session Highlights
Personnel preparation
Procedure to follow during audit-what to do/ what not to do
Facility requirements to support inspection
Behavior during inspection-what not to sign
Internal/ mock audits
483/ Warning Letter response
Who Will Benefit
Engineering personnel
Engineering management
Quality/ regulatory Management
Corporate Management
Manufacturing Management
Division management
Legal counsel
Speaker
Ed retired from industry after 30 years in management of development of medical device products and development of company Quality Systems. He was involved in the development of products such as IVD devices, kidney dialysis systems and inhalation devices. His QS experience includes, design control, risk analysis, CAPA, software validation, supplier qualification/ control and manufacturing/non-conforming product programs. He now consults in the area of quality systems for medical devices with emphasis on design control, software validation, risk analysis and human factors analysis.
Ed has a B.S. Mechanical Engineering from NYU and a M.B.A from Drexel University. He is certified by Lloyds of London as an ISO 9000 Lead Auditor and is a member of the Thomson Reuters Expert Witness network. He has 5 issued patents.
In this webinar you will learn how to prepare for an inspection and how to respond to a 483 or Warning letter if you receive one. You will learn about the types of FDA inspections, preparations such as assigning personnel to specific tasks for the inspection, facility requirements to support the inspection ( front room, back room), the value of mock audits, how personnel should conduct themselves during the inspection, the inspection process and how to respond to 483s and warning letters. How to respond and when is critically important. Also covered will be the FDA’s rights during the inspection and documentation you are not required to show them.
Session Highlights
Personnel preparation
Procedure to follow during audit-what to do/ what not to do
Facility requirements to support inspection
Behavior during inspection-what not to sign
Internal/ mock audits
483/ Warning Letter response
Who Will Benefit
Engineering personnel
Engineering management
Quality/ regulatory Management
Corporate Management
Manufacturing Management
Division management
Legal counsel
Speaker
Ed retired from industry after 30 years in management of development of medical device products and development of company Quality Systems. He was involved in the development of products such as IVD devices, kidney dialysis systems and inhalation devices. His QS experience includes, design control, risk analysis, CAPA, software validation, supplier qualification/ control and manufacturing/non-conforming product programs. He now consults in the area of quality systems for medical devices with emphasis on design control, software validation, risk analysis and human factors analysis.
Ed has a B.S. Mechanical Engineering from NYU and a M.B.A from Drexel University. He is certified by Lloyds of London as an ISO 9000 Lead Auditor and is a member of the Thomson Reuters Expert Witness network. He has 5 issued patents.
Other CFPs
- Live Webinar Understanding the FDA Compounding Pharmacies Guidance Document
- 3-Hours Live Webinar on Harmonized Tariff Schedule/Schedule B Classification
- 6-Hour Virtual Seminar on Phase I GMPs
- Strategies to Combat Counterfeit Drugs and Other Supply Chain Threats
- 3 hrs Webinar Creating and Maintaining an Effective and Efficient Technical Training Program
Last modified: 2019-07-17 21:16:13